Back to search
FDAFDA · Food and drugs·Recall number D-0691-2018

Ibuprofen Tablets USP 600 mg, a) 100 tablet (NDC 42582-112-01), b) 500 tablet bottles (NDC 42582-112-18), Rx, Distributed by Drug Mart, Food Fair, Medina, Ohio 44256

Published May 2, 2018 · Recall initiated: January 11, 2018

Summary

FDA records drug Class II recall D-0691-2018, published May 2, 2018 and initiated January 11, 2018. Recalling firm: Time-Cap Laboratories, Inc.; Status: Terminated; Reported quantity: N/A; Lot: a) C135C, exp 3/18 b) C134C, exp 3/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Time-Cap Laboratories, Inc.
Distributor
Nationwide.
Lot
a) C135C, exp 3/18 b) C134C, exp 3/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ibuprofen Tablets USP 600 mg, a) 100 tablet (NDC 42582-112-01), b) 500 tablet bottles (NDC 42582-112-18), Rx, Distributed by Drug Mart, Food Fair, Medina, Ohio 44256 recalled?

Yes. FDA published recall D-0691-2018 on May 2, 2018. Reported hazard: CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

What should I do if I have this product?

Voluntary: Firm initiated · Letter